Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5075047
Max Phase: Preclinical
Molecular Formula: C24H27ClF2N6O2
Molecular Weight: 504.97
Molecule Type: Unknown
Associated Items:
ID: ALA5075047
Max Phase: Preclinical
Molecular Formula: C24H27ClF2N6O2
Molecular Weight: 504.97
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1c(Nc2ncc3cc(Cl)c(C4CCN([C@@H]5COC[C@@H]5O)CC4)cc3n2)cnn1[C@@H]1CC1(F)F
Standard InChI: InChI=1S/C24H27ClF2N6O2/c1-13-19(10-29-33(13)22-8-24(22,26)27)31-23-28-9-15-6-17(25)16(7-18(15)30-23)14-2-4-32(5-3-14)20-11-35-12-21(20)34/h6-7,9-10,14,20-22,34H,2-5,8,11-12H2,1H3,(H,28,30,31)/t20-,21+,22-/m1/s1
Standard InChI Key: FMKVFRKEOSUZOG-BHIFYINESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 504.97 | Molecular Weight (Monoisotopic): 504.1852 | AlogP: 4.05 | #Rotatable Bonds: 5 |
Polar Surface Area: 88.33 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.60 | CX Basic pKa: 7.48 | CX LogP: 3.33 | CX LogD: 2.99 |
Aromatic Rings: 3 | Heavy Atoms: 35 | QED Weighted: 0.54 | Np Likeness Score: -0.63 |
1. Keylor MH, Gulati A, Kattar SD, Johnson RE, Chau RW, Margrey KA, Ardolino MJ, Zarate C, Poremba KE, Simov V, Morriello GJ, Acton JJ, Pio B, Yan X, Palte RL, McMinn SE, Nogle L, Lesburg CA, Adpressa D, Lin S, Neelamkavil S, Liu P, Su J, Hegde LG, Woodhouse JD, Faltus R, Xiong T, Ciaccio PJ, Piesvaux J, Otte KM, Wood HB, Kennedy ME, Bennett DJ, DiMauro EF, Fell MJ, Fuller PH.. (2022) Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors., 65 (1.0): [PMID:34967623] [10.1021/acs.jmedchem.1c01968] |
Source(1):